ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
4 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
4
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
9 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
9
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
23 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
23
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
56 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
56
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
Fact Finder
|
315 |
124K |
29 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
315
|
124K
|
29
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
92 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
92
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
31 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
31
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
106 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
106
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
3 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
3
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
5 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
5
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
10 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
10
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
36 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
36
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
Fact Finder
|
315 |
124K |
18 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
315
|
124K
|
18
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
11 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
11
|
|
ASX - By Stock
|
BRN |
Re:
Australian Defence Force
|
|
Fact Finder
|
119 |
47K |
32 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
119
|
47K
|
32
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
15 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
15
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
4 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
4
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
47 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
47
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
22 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
22
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
33 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
33
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
56 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
56
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
35 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
35
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
15 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
110
|
49K
|
15
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
167 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
167
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
44 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
44
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
Fact Finder
|
315 |
124K |
14 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
315
|
124K
|
14
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
2 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
Fact Finder
|
315 |
124K |
24 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
315
|
124K
|
24
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
26 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
26
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
6 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
6
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
9 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
9
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
12 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
12
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
26 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
26
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
34 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
34
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
9 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
9
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
41 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
41
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
9 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
9
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
15 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
15
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
47 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
47
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
21 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
21
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
135 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
135
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Fact Finder
|
110 |
49K |
148 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
110
|
49K
|
148
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
50 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
50
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
59 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
59
|
|
ASX - By Stock
|
BRN |
Re:
BRN Trading short term
|
|
Fact Finder
|
79 |
23K |
62 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
79
|
23K
|
62
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
83 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
83
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
18 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
18
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
Fact Finder
|
315 |
124K |
67 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
315
|
124K
|
67
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
16 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
16
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Fact Finder
|
10K |
4.7M |
62 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
62
|
|